|Year : 2021 | Volume
| Issue : 3 | Page : 125-132
Medical device-related counseling practice and barriers among Sudanese pharmacists: A questionnaire-based study
Ahmed Ibrahim Fathelrahman
Department of Clinical Pharmacy, Taif University, Taif, Saudi Arabia
|Date of Submission||11-Mar-2021|
|Date of Acceptance||19-Sep-2021|
|Date of Web Publication||25-Dec-2021|
Dr. Ahmed Ibrahim Fathelrahman
Department of Clinical Pharmacy, Taif University, Taif
Source of Support: None, Conflict of Interest: None
Objective: The aim of the present study was to assess medical devices-related counseling practice and barriers among pharmacists. Methods: This was a cross-sectional study conducted using a convenient sample of Sudanese pharmacists. An online-version survey was used to collect data. Findings: One hundred and thirty pharmacists responded to the online survey. Most pharmacists in this sample were master or Ph.D. degree holders (62.3% and 12.3%, respectively), having a clinical training experience (70%) and substantial proportion are board-certified (30%). Medical devices reported to be commonly inquired by patients were blood glucose monitors, nebulizers, blood pressure monitors, dry powder inhalers, and insulin pens. Devices most frequently requiring counselling were blood glucose monitors, blood pressure monitors, syringes, thermometers, nebulizers, dry powder inhalers, insulin, and weighing scales. The most frequently supplied devices reported were syringes, blood glucose monitors, insulin pens, blood pressure monitors, thermometers, nebulizers, and dry powder inhalers. Devices least frequently requiring counselling were implanted devices, respirometers, and stethoscopes. The least frequently supplied devices were respirometers, implanted devices, and heart rate monitors. Conclusion: Medical devices reported to be commonly inquired by patients were most frequently requiring counseling, and most frequently supplied. Findings reflect the availability of devices in the market and pharmacists' response to the needs of their patients. Pharmacists should maintain adequate knowledge about the proper use of medical devices because this is a common patient inquiry.
Keywords: Barriers to counseling, counseling practices, medical devices, medical supply, pharmacists, questionnaire, Sudanese population
|How to cite this article:|
Fathelrahman AI. Medical device-related counseling practice and barriers among Sudanese pharmacists: A questionnaire-based study. J Res Pharm Pract 2021;10:125-32
|How to cite this URL:|
Fathelrahman AI. Medical device-related counseling practice and barriers among Sudanese pharmacists: A questionnaire-based study. J Res Pharm Pract [serial online] 2021 [cited 2022 May 22];10:125-32. Available from: https://www.jrpp.net/text.asp?2021/10/3/125/333715
| Introduction|| |
Pharmacists are professional expert in medications. Besides compounding and dispensing, they provide accurate unbiased medicine information to the healthcare providers and patients. They counsel patients to resolve actual drug-related problems and prevent others. Pharmacists are effective counselors on therapeutic issues because of pharmaceutical care experience accumulated worldwide through decades across generations of pharmacists. Evidence shows positive effects of counseling on patients' clinical, humanistic, and economic outcomes.,,, However, some areas related to therapy remained overlooked. Medical devices are a good example for such underserved areas of practice. The wide availability of medical devices in various settings of practice put pharmacists under a great challenge to keep pace with this fast-developing and ever-evolving field of practice.
Many devices are used by patients to monitor the status or to achieve the control of a disease. This is like blood glucose monitors and blood pressure monitors. Such devices are sophisticated, affected by the inappropriate operation, storage or maintenance and the interpretation of their readings needs careful considerations. The public routinely seeks help from pharmacists to explain devices' proper use and to solve problems arising during operation.
There is an increase in the number of devices that act as medications' carriers starting from asthma treatments devices like metered-dose inhalers, accuhalers, turbuhalers, spacers, and nebulizers and ending with more sophisticated devices like insulin pens that help patients accurately adjust doses of their medications on daily bases.,,
Some devices are implanted in patients' bodies to make control of a condition or a function such as cardiac pacemakers, implantable cardiac defibrillators, coronary stents, hip implants, interocular lenses, and implantable insulin pumps. Patients who have implanted devices need specific pharmacotherapeutic care like the use of anticoagulants and other considerations. Moreover, the use of some devices is associated with high risk of infections.
All above considerations require that pharmacists counsel patients about medical devices in all settings of practice. It has been reported that community pharmacists consider counseling and dispensing of personal medical devices as a traditional service of community pharmacy. However, medical device-related counseling practice has not been investigated sufficiently among pharmacists in the literature and to our knowledge this issue has not been assessed in Sudan or Africa. The readiness of Sudanese pharmacists to counsel patients on medical devices has been evaluated elsewhere. However, the previous study did not evaluate pharmacists' practice. Our hypothesis was that pharmacists counsel patients on the medical devices they know, and they are familiar with. There would be shortages incounseling on sophisticated and uncommon devices. Barriers to counseling identified by previous studies such as lack of knowledge, time, and lack of relevant training may be preventing pharmacists from playing their role in this area effectively.
The aim of the present study was to evaluate medical device-related counseling practice and barriers among Sudanese pharmacists. Specifically, the study aimed to answer five research questions; (a) what devices represent patients' common inquiry? (b) how frequently pharmacists counsel patients about devices? (c) how frequently they supply devices? (d) how they perceived the need for certain measures related to medical devices? (e) and what are the common barriers to counseling about medical devices?
| Methods|| |
Using a convenience sampling technique, a sample of Sudanese pharmacists participated in a cross-sectional study that was performed from February to June 2020.
Sudanese pharmacists working in different pharmaceutical sectors including community pharmacy, hospital pharmacy, industry (i.e., manufacturing, quality control, and drug promotion), regulatory authority, health insurance sector, and others were eligible to participate in the study. The study included pharmacists who are currently working inside the country or overseas.
The original survey included 11 parts and current analyses covers six, as follows: (a) pharmacists' demography and background information, (b) Medical devices that were reported to be commonly inquired by patients (5-point Likert Scale; never, rarely, sometimes, often, and always), (c) devices that were reported to be most frequently items requiring counselling (5-point Likert Scale; never, rarely, sometimes, often, and always), (d) Devices that were reported to be most frequently items supplied (5-point Likert Scale; never, rarely, sometimes, often, and always), (e) Pharmacists' perceived need for certain measures intended to enhance medical devices-related practice (5-point Likert Scale; strongly disagree, disagree, neutral, agree and strongly agree), and (f) the barriers to counsel patients about medical devices (5-point Likert Scale; strongly disagree, disagree, neutral, agree, and strongly agree).
The list of 20 medical devices covered by the study was decided based on their availability in practice either in the community or hospital settings given that they represent a variety of clinical specialties. The preliminary drafted survey questions and the list of devices were edited and approved by a group of academic staff with excellent experiences in pharmacy practice and healthcare service research.
The survey was prepared as an online format using Google forms. The survey link was sent primarily to pharmacists via Sudanese professional groups in WhatsApp and Facebook. Some key pharmacists from different sectors were asked to distribute the link to other special pharmacy professional groups. Frequent reminders were sent to encourage participation in the survey.
The preliminary plan was to recruit a sample of 400–500 pharmacists to represent the population of Sudanese pharmacists estimated to be at least 5000 (i.e., about 10%) according to the more recent available statistics.
On the other hand, using the software “PS Power and Sample Size Program,” it was found that a sample size of at least 64 participants per group was enough to detect a significant difference between two groups (i.e., total 128) using Student's t-test with a power of 0.8, α (i.e., significance level) =0.05, σ (sigma: Within-group standard deviation) =0.6, and δ (delta: A difference in population mean) =0.3.
An ethical approval of the study protocol was obtained from the Taif university research ethics committee (reference number 41-00193). Pharmacists were notified that participation is voluntary. Also, they were told that data will be analyzed and presented anonymously, and that nothing can be used to reveal their identity. All agreed to participate in the survey.
Data were analyzed and presented descriptively and comparatively using IBM SPSS statistics for windows, version 22.0, Armonk, NY, USA. IBM Corp. The original questions were treated and analyzed firstly as qualitative variables and presented as frequencies and percentages showing how pharmacists responded to the questions. Average scores on how frequently medical devices represent patients' inquiry, counseling, and supply have been computed out of 5-point Likert Scale (i.e., never = 1, rarely = 2, sometimes = 3, often = 4, and always = 5). Such derived variables were treated as quantitative variables. Cronbach's alpha was used to assess the internal consistency/reliability (i.e., how closely related a set of items are as a group) of the items constituting one construct with total computed scores; namely “how frequently medical devices represent patients' common inquiry, to what extent do pharmacists normally counsel their patients about devices, and to what extent do pharmacists normally supply devices to their patients with or without counseling? A Cronbach's alpha of 0.8 -<9 represents good reliability and that of ≥9 represents excellent reliability. Comparisons between groups were conducted using Student's t-test concerning the variables gender, residence (overseas versus inside Sudan), board certification, and clinical training. One-way ANOVA was used to test for differences between groups concerning the variables age group, sector, years of experience, work location (rural, suburban, and urban), and highest qualifications. A P < 0.05 was considered statistically significant.
| Results|| |
Hundred and thirty pharmacists responded to the online survey. The highest number of pharmacists were from the age group 35–44 years (33.1%), followed by age group “25–34 years (28.5%), then age group 45–54 years (26.2%), age group ≥55 years (10.8%) and age <25 years (1.5%). Males (53.8%) were slightly more than females. Bachelor's, Master's, Doctor of Pharmacy (PharmD), and Doctor of Philosophy (PhD) holders represented 23.1%, 62.3%, 2.3%, and 12.3% of participants, respectively. Respondents located inside Sudan represented about two-thirds (65.4%) and the rest (34.6%) were overseas. Most of the latter group were residents of Gulf countries (25.4% of all respondents and 73.3% of overseas). By sector, most of the respondents were from academia (30.8%) followed by community pharmacy (25.4%), hospital pharmacy (14.6), regulatory affairs (10.8%), insurance sector (5.4%), drug marketing and promotion (5.4%), pharmaceutical manufacturing (production and Q.C., 3.8%), research institution (2.3%) and nongovernmental organization (1.5%). For comparative analyses, the two sectors “academia” and “research institutions” were added together in one group and the two sectors “marketing and promotion” and “pharmaceutical manufacturing” were added together in one group entitled “pharmaceutical industry”. Most of the respondents received clinical training (70%) and about one-third got a board certification (30%).
Cronbach's alpha showed high reliability of the 20 questions on the devices inquired by patients (Cronbach's alpha = 0.912). Five devices reported to be commonly inquired by patients start with blood glucose monitors, followed by nebulizers, blood pressure monitors, dry powder inhalers, and insulin pens [Table 1]. Implanted devices, stethoscopes, respirometers, and meters were reported to be the least commonly inquired by patients.
Cronbach's alpha showed high reliability of the 20 questions on the devices most frequently requiring counseling (Cronbach's alpha = 0.937). Devices most frequently requiring counseling reported by pharmacists included blood glucose monitors, followed by blood pressure monitors, syringes, thermometers, nebulizers, dry powder inhalers, insulin pens, and weighing scales [Table 2]. Devices least frequently requiring counseling reported by pharmacists included implanted devices, respirometers, and stethoscopes.
|Table 2: Devices most frequently requiring counseling reported by our sample of pharmacists|
Click here to view
Cronbach's alpha showed high reliability of the 20 questions on the most frequently supplied devices (Cronbach's alpha = 0.938). Syringes came first as the most frequently supplied device, followed by blood glucose monitors, insulin pens, blood pressure monitors, thermometers, dry powder inhalers, and nebulizers [Table 3]. Devices that were reported to be the least frequently supplied items included respirometers, implanted devices, and heart rate monitors.
|Table 3: Most frequently supplied devices reported by our sample of pharmacists|
Click here to view
Special training provided to pharmacy students and for practicing pharmacists as a part of Continuing Professional Development (CPD) program were two measures got the agreement of the highest proportion of respondents [83.1% each, [Table 4]]. The other measures (a didactic course for pharmacy students and a reference book) still got the acceptance of most respondents (81.6% and 73.1%, respectively).
|Table 4: Pharmacists' perceived need for certain measures intended to enhance devices-related practices|
Click here to view
Barriers got the greatest agreement of respondents [Table 5] were “workload in pharmacy” (37%), “non-supportive policies” (33.9%), “lack of knowledge” (33.8%), and “time” (32.3%). Substantial proportion of respondents (72.3%) did not agree that “customers/patients do not trust pharmacists” is a barrier.
There were no significant differences (in average scores) by gender, clinical training, sector, age group, years of experience, work location, and highest qualifications in the average scores rating devices being commonly inquired by patients, devices requiring counseling, and the devices being supplied to patients. However, overseas pharmacists reported significantly more counseling activity on medical devices compared to those residents in Sudan [Table 6]. Board-certified pharmacists reported significantly more counseling activity on medical devices and received significantly more inquiries from patients.
|Table 6: Differences by residence and board certification regarding how frequently medical devices represent patients' inquiry, counseling, and supply|
Click here to view
| Discussion|| |
The present study revealed a set of findings that help understanding pharmacists' practice regarding medical devices. Findings will assist in improving pharmacists' practice via designing training and educational needs of both pharmacists and pharmacy students and setting supportive policies and regulations. Blood pressure monitors and blood glucose monitors in addition to others were among the top five medical devices reported to be commonly inquired by patients, most frequently requiring counseling, and most frequently supplied. The two devices were commonly available in community pharmacy practice. Thus, findings reflect the availability of devices in the market and the pharmacists' effective response to the needs of their patients. Barriers to medical device-related counseling practice included workload in pharmacy, nonsupportive policies, lack of knowledge, and time. This supports the finding shown by Rasheed et al. who have reviewed the literature on the community pharmacists' counseling practice in Saudi Arabia.
In terms of qualification, most pharmacists in this sample were master's or Ph.D. degree holders, having clinical training experience, and substantial proportion of them are board-certified. Clinical training includes hospital training that involves direct interaction with patients taken as part of a master's, postgraduate diploma, CPD, or training attachment because most of the pharmacists in the country were bachelor's degree (BSc) holders without formal clinical training during the study. Board certification includes for example certification of the American Board of Clinical Pharmacotherapy and the American Board of Clinical Nutrition Support Pharmacy which are taken via examination only and do not include actual practical training.
In most situations, medical devices reported to be commonly inquired by patients were most frequently requiring counseling, and most frequently supplied despite the presence of some variability in ranking. According to rank, devices reported to be commonly inquired by patients were blood glucose monitors, nebulizers, blood pressure monitors, dry powder inhalers, and insulin pens. Devices most frequently requiring counselling were blood glucose monitors, blood pressure monitors, syringes, thermometers, nebulizers, dry powder inhalers, insulin pens, and weighing scales. Devices most frequently supplied were syringes, blood glucose monitors, insulin pens, blood pressure monitors, thermometers, dry powder inhalers, and nebulizers.
Devices like syringes are used by families in Sudan and other countries to measure oral liquid medications. Evidence shows a need for a demonstration of the correct way to use such devices for that purpose. The demonstration is important and effective educational technique that should be incorporated in counseling to teach patients on proper devices' use. Research on inhaler devices revealed that the provision of active device technique education improves device technique in older adults. In addition, a simple feasible intervention incorporating daily reminders via inhaler technique labels leads to an improvement in inhaler technique and asthma outcomes. In Jordan, the pharmacist-led educational intervention resulted in improved inhaler technique scores. Using only actual demonstration with inhaler device counseling showed superior improvement in performance.
The benefits that can be gained by patients and customers from proper counseling on medical devices are diverse. Patients' convenience and satisfaction with their devices affect their adherence to the pharmacological treatment which in turn affects their health outcomes and costs. Arora et al. concluded that “proper education to patients on correct usage may not only improve control of the symptoms of the disease but might also allow dose reduction in long time.”
In our study, overseas pharmacists reported better medical device-related counseling practice. Most overseas pharmacists in this sample were residents of Gulf countries. The presence of policies supportive of medical devices industry and encouraging pharmacists to serve patients and customers with their device-related needs might explain such findings. According to Howard, Gulf Cooperation Council countries including Saudi Arabia, the United Arab Emirates, and Qatar represent fertile ground for the development of medical technologies and have favorable conditions for the medical device market. Svarstad reported that counseling practices varied significantly according to the intensity of a state's counseling regulation. This implies that counseling practice may differ widely by country according to the available policies. Another explanation of the previously stated finding would be the availability of such devices in the market and pharmacists' regular exposure to them.
On the other hand, the nature of different sectors and practice settings would be expected to play a role in the pharmacists' variability of practice. Schommer and Wiederholt found that pharmacists in different practice settings and positions reported different counseling-related barriers and facilitators. Evidence shown that the success of educational inhaler technique interventions differed by practice setting where outpatient clinics performed best. However, in contrast to the former evidence, there were no significant differences between our pharmacists by sector concerning medical devices reported to be commonly inquired by patients, devices most frequently requiring counseling, and devices most frequently supplied.
A limitation of the present study was the small sample size. In addition, a limitation that is inherent in surveys in general which is applicable to this study is the recall bias. The setting of the study was another limitation which limits the generalizability of findings. Thus, there is a need to replicate the study in a larger sample of community pharmacists to support the preliminary findings of this study. To our knowledge, this is the first study evaluating medical device-related counseling practice and barriers among pharmacists in Sudan and Africa.
The study revealed a variable but acceptable counseling practice across a variety of devices. Medical devices reported to be commonly inquired by patients were most frequently requiring counseling, and most frequently supplied. Findings reflect the availability of devices in the market and pharmacists' response to the needs of their patients. Findings suggest pharmacists should maintain adequate knowledge about the proper use of medical devices because this is a common patient inquiry.
| Authors' Contribution|| |
All work in this research was done by the sole author of this paper Ahmed Fathelrahman. Assistance provided by others is declared in the following acknowledgment.
The author would like to acknowledge the assistance of the following colleagues in the validation of the questionnaire for the face and content; Professor Ab Fatah Ab Rahman from Faculty of Medicine and Health Sciences, Universiti Sultan Zainal Abidin, Malaysia, Professor Mohamed Izham Mohamed Ibrahim from College of Pharmacy, Qatar University; Professor Ahmed Awaisu from College of Pharmacy, Qatar University; Dr Ali Alshahrani from College of Pharmacy, Taif University, Saudi Arabia, Dr Mona Alshiekh from College of Pharmacy, Taif University, Saudi Arabia; and Dr Fathielrahman Ibrahim Fathielrahman, MD, Ophthalmology.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
McGivney MS, Meyer SM, Duncan-Hewitt W, Hall DL, Goode JV, Smith RB. Medication therapy management: Its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc (2003) 2007;47:620-8.
Wang KY, Chian CF, Lai HR, Tarn YH, Wu CP. Clinical pharmacist counseling improves outcomes for Taiwanese asthma patients. Pharm World Sci 2010;32:721-9.
Okumura LM, Rotta I, Correr CJ. Assessment of pharmacist-led patient counseling in randomized controlled trials: A systematic review. Int J Clin Pharm 2014;36:882-91.
Sanii Y, Torkamandi H, Gholami K, Hadavand N, Javadi M. Role of pharmacist counseling in pharmacotherapy quality improvement. J Res Pharm Pract 2016;5:132-7.
] [Full text]
AlShayban DM, Naqvi AA, Islam MA, Almaskeen M, Almulla A, Alali M, et al.
Patient satisfaction and their willingness to pay for a pharmacist counseling session in hospital and community pharmacies in Saudi healthcare settings. Front Pharmacol 2020;11:138.
Ratassepp T, Shagandina A, Turunen J, Ahonen R, Heinämäki J, Volmer D. Counseling in the use of personal medical devices and drug-delivery products – A traditional or extended community pharmacy service. Farmacia 2015;63:388-93.
Olczuk D, Priefer R. A history of continuous glucose monitors (CGMs) in self-monitoring of diabetes mellitus. Diabetes Metab Syndr 2018;12:181-7.
Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med 1999;106:57-8, 61-4, 68.
Ashurst II, Malton A, Prime D, Sumby B. Latest advances in the development of dry powder inhalers. Pharm Sci Technol Today 2000;3:246-56.
Pearson TL. Practical aspects of insulin pen devices. J Diabetes Sci Technol 2010;4:522-31.
Kenneth Ward W. A review of the foreign-body response to subcutaneously-implanted devices: The role of macrophages and cytokines in biofouling and fibrosis. J Diabetes Sci Technol 2008;2:768-77.
Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004;17:255-67.
Fathelrahman AI. Readiness of Sudanese pharmacists to counsel patients about medical devices. Adv Pharmacol Pharm 2020;8:59-65.
Rasheed MK, Hasan SS, Babar ZU. Community pharmacist's knowledge, attitude, roles and practices towards patient-centred care in Saudi Arabia: A systematic review of the literature. J Pharm Health Serv Res 2019;10:101-15.
Alfadl AA, Ali GK, Yousif MA, Babekir MF. Pharmacy practice in Sudan. In: Fathelrahman AI, Ibrahim MI, Wertheimer AI, editors. Pharmacy Practice in Developing Countries. London, San Diego, Cambridge, Oxford: Elsevier, Academic Press; 2016. p. 319-41.
Almazrou S, Alsahly H, Alwattar H, Alturki L, Alamri M. Ability of Saudi mothers to appropriately and accurately use dosing devices to administer oral liquid medications to their children. Drug Healthc Patient Saf 2015;7:1-6.
Crane MA, Jenkins CR, Goeman DP, Douglass JA. Inhaler device technique can be improved in older adults through tailored education: Findings from a randomised controlled trial. NPJ Prim Care Respir Med 2014;24:14034.
Basheti IA, Armour CL, Bosnic-Anticevich SZ, Reddel HK. Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique. Patient Educ Couns 2008;72:26-33.
Basheti IA, Salhi YB, Basheti MM, Hamadi SA, Al-Qerem W. Role of the pharmacist in improving inhaler technique and asthma management in rural areas in Jordan. Clin Pharmacol 2019;11:103-16.
Fink JB. Inhalers in asthma management: Is demonstration the key to compliance? Respir Care 2005;50:598-600.
Mäkelä MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med 2013;107:1481-90.
Arora P, Kumar L, Vohra V, Sarin R, Jaiswal A, Puri MM, et al.
Evaluating the technique of using inhalation device in COPD and bronchial asthma patients. Respir Med 2014;108:992-8.
Howard JJ. Medical devices and the Middle East: Market, regulation, and reimbursement in Gulf Cooperation Council states. Med Devices (Auckl) 2014;7:385-95.
Svarstad BL, Bultman DC, Mount JK. Patient counseling provided in community pharmacies: Effects of state regulation, pharmacist age, and busyness. J Am Pharm Assoc (2003) 2004;44:22-9.
Schommer JC, Wiederholt JB. Pharmacists' perceptions of patients' needs for counseling. Am J Health Syst Pharm 1994;51:478-85.
Klijn SL, Hiligsmann M, Evers SM, Román-Rodríguez M, van der Molen T, van Boven JF. Effectiveness and success factors of educational inhaler technique interventions in asthma and COPD patients: A systematic review. NPJ Prim Care Respir Med 2017;27:24.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6]